BOSTON, MA, (December 3, 2020)—Rich Horgan, Founder & President of Cure Rare Disease™ (CRD), has been recognized by ‘Forbes 30 under 30’ in the Healthcare category for 2021, a nod to his leadership in the groundbreaking development of customized therapeutics for those who have...

Newton, Mass. December 2, 2020 – Change Logic, a strategic business consultancy, is announcing a core set of innovation practices that provide organizations with effective ways to develop and incubate ideas that can help them successfully scale in the marketplace during unprec...

Carlsbad, Calif.—SPY+ has always been a bit beyond control, and its new augmented reality filter gives retailers and brand loyalists an unrestricted way to showcase and experience its brand-new Marauder snow goggle. Moreover, SPY+ is the first eyewear brand to deploy Google's ...

San Francisco, Calif., December 2, 2020 — RealKey, an innovative provider of digital mortgage technology, today announced that it was one of three companies selected for the Flagstar Bank MortgageTech Accelerator Program. The MortgageTech Accelerator focuses on startups activ...

UGI Utilities, Inc. announced its purchased gas cost rates will decrease on December 1, 2020 reducing the average residential heating customer’s bill by 1.1 percent. As a result, the average bill will decrease from $79.37 per month to $78.47 per month.  “UGI is pleased to pas...

NEW YORK, Nov 30, 2020 // Rounding out a season of giving, Minneapolis-based ADX Foundation donates $30,000 to WhyHunger for hunger alleviation. The ADX Foundation is the charitable arm of Minneapolis-based company ADX Labs, Inc. The ADX Foundation is a private foundation esta...

HAUPPAUGE, NY (Nov. 30, 2020) – COVAXX, a U.S. company developing a synthetic multitope peptide-based vaccine to fight COVID-19, today announced that Chief Scientific Officer Farshad Guirakhoo, Ph.D. will participate in the Opening Keynote panel discussion, “SARS-CoV-2 - We ha...

HAUPPAUGE, NY (Nov. 25, 2020) – COVAXX, a U.S. company developing a multitope peptide-based vaccine to fight COVID-19, announces advanced purchase commitments of more than 140 million doses of its UB-612 vaccine, totaling over $2.8 billion, to deliver vaccines in multiple coun...

Burlingame, Calif., October 29, 2020  — Inflammatix a pioneering molecular diagnostics company, announced today a contract extension of $7.4 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Service...

November 19, 2020 -- Boston, MA & Singapore -- AIM Biotech completed its series A financing to accelerate growth of its organ-on-a-chip business. The company’s advanced research tool mimics human organs and disease models in the lab to improve, accelerate and reduce the cost o...